Translation, Cultural Adaptation, and Validation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) and Self‐Complete Leeds Assessment of Neuropathic Symptoms and Signs (S‐LANSS) Questionnaires into the Greek Language

Batistaki, Chrysanthi; Lyrakos, G.; Drachtidi, Kalliopi; Stamatiou, Georgia; Kitsou, Maria-Chrysanthi; Kostopanagiotou, Georgia

doi:10.1111/papr.12300

Cited by 11 publications

(15 citation statements)

References 21 publications

(28 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our results demonstrated a good test-retest reliability for LANSS (ICC 0.76). e original LANSS version did not assess test-retest reliability [4], and our findings are similar to those of Batistaki et al that showed a strong correlation between the two evaluations (r � 0.94, p < 0.001) in Greek translation of LANSS [16].…”

Section: Discussionsupporting

confidence: 89%

See 1 more Smart Citation

Cross Cultural Adaptation and Validation of Italian Version of the Leeds Assessment of Neuropathic Symptoms and Signs Scale and Pain DETECT Questionnaire for the Distinction between Nociceptive and Neuropathic Pain

Migliore

Gigliucci

Moretti

et al. 2021

Pain Research and Management

View full text Add to dashboard Cite

Objective. This study aimed to validate Italian versions of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) scale and Pain DETECT questionnaire (PD-Q) and evaluate the ability of these questionnaires to discriminate between nociceptive and neuropathic pain. Design. Multicenter prospective validation cohort study. Subjects and Setting. One hundred patients were included with a diagnosis formulated by a specialist in outpatient settings (50 affected by knee osteoarthritis as nociceptive pain and 50 affected by trigeminal or postherpetic neuralgia as neuropathic pain). Methods. The Italian versions of both questionnaires according to Italian cultural characteristics were performed according to the following steps: (1) translation of the questionnaires from English into Italian; (2) review by a bilingual individual for consistency; (3) proposed version after a mail round between experts; (4) backward translation; (5) comparison with the original English version by the experts; (6) approved version of the questionnaires. One hundred patients were enrolled and completed the two questionnaires administered by a specialist or blinded nursing staff, at the baseline and after 24/48 hours. Internal consistency, stability, validity, and discriminative power were analyzed. Results. Statistically significant differences were reported about the ability of both questionnaires to discriminate between patients affected by neuropathic or nociceptive pain. Internal consistency for the Italian version of the LANSS was 0.76, and for PD-Q, it was 0.80, assessed by Cronbach’s α; LANSS showed a good test-retest reliability with an ICC of 0.76, and PD-Q showed a high test-retest reliability with an ICC of 0.96. For interrater reliability, there was a concordance rate of 83.3% between reference diagnosis and LANSS (Cohen’s kappa = 0.67, CI 95% 0.52–0.75). Conclusions. This study validated the Italian versions of LANSS and PD-Q as reliable instruments with good psychometric characteristics, for pain evaluation, discriminating between nociceptive and neuropathic pain. Our findings were similar to those observed in the original study. Furthermore, we have reported the test-retest reliability for both questionnaires, not addressed in original validation studies.

show abstract

Section: Discussionsupporting

confidence: 89%

“…For reliability, LANSS internal consistency was determined as acceptable with a Cronbach's-α of 0.76 in line to the result demonstrated in the original study (Cronbach's-α of 0.74) [4], while a lower Cronbach's-α value (0.65) was shown by Batistaki et al in the Greek LANSS validation study [16].…”

Section: Discussionsupporting

confidence: 75%

Cross Cultural Adaptation and Validation of Italian Version of the Leeds Assessment of Neuropathic Symptoms and Signs Scale and Pain DETECT Questionnaire for the Distinction between Nociceptive and Neuropathic Pain

Migliore

Gigliucci

Moretti

et al. 2021

Pain Research and Management

View full text Add to dashboard Cite

show abstract

“…An advantage of the S-LANSS scale is that it can also be used by nonspecialists. [ 21 ] This would also be a solution to underdiagnosis by busy physicians and general practitioners. If screened effectively, patients will not have to visit tertiary cancer hospitals for specialist pain management.…”

Section: Discussionmentioning

confidence: 99%

“…It has been validated in a diverse population across the globe and has demonstrated internal consistency (Cronbach's alpha) from 0.6 to 0.74. [ 20 21 22 ] A palliative care physician cum researcher administered the questionnaire to the eligible patients in the interview format. Adequate internal consistency was demonstrated in the current sample (Cronbach's alpha –0.67).…”

Section: Ethodologymentioning

confidence: 99%

The burden of cancer-related neuropathic pain: A multi-centric cross-sectional observational study from North India

Satija

Joad

Rana

et al. 2021

Indian J Palliat Care

View full text Add to dashboard Cite

Introduction: Neuropathic cancer pain is a common consequence of cancer itself and anti-cancer treatments. It is a complex phenomenon, often underdiagnosed by physicians or underreported by patients. Its diagnosis and management are usually more challenging than nociceptive pain. There is a dearth of epidemiological evidence for neuropathic pain in cancer patients in India. Screening questionnaires serve as a quick guide to identify potential cases of neuropathic pain. The aim of the present study was to identify the burden of cancer-related neuropathic pain using the Self-reported version of the Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) pain scale. Methodology: This was a cross-sectional, observational, multi-centric study conducted at three hospitals in North India. From January 2017 to October 2017, patients attending pain clinic were screened for participation in the study. Adults aged ≥18 years and experiencing the pain of oncologic origin were eligible to participate in the study if they provided informed consent. S-LANSS questionnaire was used to screen patients with neuropathic pain. Results: From a total of 261 patients, who were enrolled in the study, 56.7% were male and their mean age was 50.87 (18–80) years. Fifty-four percent patients had pain with predominantly neuropathic component (S-LANSS score ≥10). Conclusion: High burden of neuropathic cancer pain has been observed in outpatient palliative care settings. Early diagnosis of neuropathic pain through screening questionnaires can serve as a quick guide for physicians in resource-constrained settings. This will allow identification of the neuropathic component of pain in patients suffering with mixed pain.

show abstract

“…The meticulous clinical assessment by pain specialists is a fundamental procedure in the diagnosis of neuropathic pain in cancer patients. The tools used to evaluate the intensity of pain—such as the numeric rating scale (NRS) and visual analog scale (VAS)—or more complicated tools for evaluating its impact on patients, such as the Brief Pain Inventory, are not adequate for neuropathic pain assessment, as they do not focus on the distinct characteristics of neuropathic pain, particularly in cancer patients …”

Section: Introductionmentioning

confidence: 99%

Detection of Neuropathic Pain in End‐Stage Cancer Patients: Diagnostic Accuracy of Two Questionnaires

et al. 2018

View full text Add to dashboard Cite

show abstract

Translation, Cultural Adaptation, and Validation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) and Self‐Complete Leeds Assessment of Neuropathic Symptoms and Signs (S‐LANSS) Questionnaires into the Greek Language

Abstract: The LANSS and the S-LANSS diagnostic tools have been translated and validated into the Greek language and can be adequately used to assist the identification of neuropathic pain in everyday clinical practice.

Cited by 11 publications

References 21 publications

Cross Cultural Adaptation and Validation of Italian Version of the Leeds Assessment of Neuropathic Symptoms and Signs Scale and Pain DETECT Questionnaire for the Distinction between Nociceptive and Neuropathic Pain

Cross Cultural Adaptation and Validation of Italian Version of the Leeds Assessment of Neuropathic Symptoms and Signs Scale and Pain DETECT Questionnaire for the Distinction between Nociceptive and Neuropathic Pain

The burden of cancer-related neuropathic pain: A multi-centric cross-sectional observational study from North India

Detection of Neuropathic Pain in End‐Stage Cancer Patients: Diagnostic Accuracy of Two Questionnaires

Contact Info

Product

Resources

About